European Journal of Obstetrics & Gynecology and Reproductive Biology
Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania
Introduction
There are many cancers that strike young males who have not yet started or completed families. Studies have shown that a significant number of male cancer patients have the desire to have children and that anxiety about the potential for infertility exists [1]. Chemotherapy and radiation are the mainstays of successful cancer treatment, but often lead to diminished fertility and, in some cases, irreversible impairment of spermatogenesis. For instance, chemotherapeutic agents are known to damage germinal epithelial cells and cause Leydig cell dysfunction. Likewise, radiation treatments at doses >1–2 Gy are mutagenic and destructive to germ cells [2], [3]. Due to the effectiveness of these cancer treatments, the overall 5 year survival rates for the two most common tumors affecting males have greatly improved, and were recently reported as 95% for testicular cancer and 82% for Hodgkin’s disease [4]. Although efforts have been made to modify protocols in order to minimize effects on fertility, the chances of fathering children after treatment remain difficult to predict. Depending on the chemotherapeutic agent and the duration of treatment, 45–80% of patients will have permanent gonadal dysfunction resulting in azoospermia [5].
Cryopreservation of sperm has provided hope for fertility preservation in cancer patients. Ideally, it should be offered prior to initiation of cancer therapy, but it can also be done for patients already undergoing treatment. Sperm cryopreservation prior to the initiation of chemo- or radiotherapy is advantageous because the quality of the sample may be compromised even after a single treatment session. However, depending on the type of cancer and the overall condition of the patient, sperm quality may be poor even in patients who have not yet started therapy [6]. The precise mechanisms of abnormalities in sperm production prior to cancer therapy are not clear, but may be related to type of cancer, emotional stress, fever, and immune-mediated factors.
Reports suggest that most young male patients diagnosed with cancer do not utilize cryopreservation. The most commonly cited reason among cancer patients for not banking sperm has been that they were never adequately informed of their options [7]. There appears to be a lack of awareness among both patients and physicians, which may be due to the fact that the service of sperm cryostorage for cancer patients is not widely publicized. There is a paucity of reports on the demographics of oncology patients who do freeze their sperm, the timing of collection relative to cancer therapy, and the potential use of the samples for reproduction. This epidemiologic information, which we aim to present in this paper, is essential to physicians in counseling their patients. We conducted a review of all male cancer patients who have elected to freeze their sperm at our institution over the past 10 years. We assessed types of cancer, patient age, timing of collection, and duration of storage. We evaluated and compared pre-therapy semen properties of patients from different cancer groups to determine whether certain cancer types rendered patients more susceptible to poor semen quality. We also report specimen disposal, sperm beneficiaries and utilization rates for reproductive purposes. For those patients who discontinued storage, we looked at reasons for discontinuation including death.
Section snippets
Materials and methods
We performed a review of our cryopreservation database, including all oncologic patients who had submitted specimens between June 1993 and March 2003. All patients were referred by their primary oncologists. Each patient’s initial visit consisted of an interview and consultation with an attending physician, during which a complete medical, surgical and social history was gathered, as well as information regarding prior fertility. Additionally, a detailed consent form was issued, which described
Results
There were a total of 164 cancer patients who cryopreserved sperm during the study period. Patient characteristics are listed in Table 1. The mean age at first freeze was 29.5±7.1 years, ranging from 13 to 58 years of age. The number of samples collected was determined by the patient and his treatment plan, and ranged between one and nine samples. The types of cancer were diverse (see Table 2). Testicular cancer, Hodgkin’s lymphoma, and leukemia comprised the majority.
Thirty three patients
Discussion
Given the estimated frequency of cancers diagnosed in young males, the epidemiological review of our database suggests that sperm cryostorage for fertility preservation in cancer patients is clearly under-utilized. An estimate of 2% of all males between the ages of 18 and 44 will be diagnosed with cancer per year in the United States [8]. Unfortunately, this accumulation of new cancer cases has not been reflected in the number of patients seeking cryopreservation services. Over a 10-year
Condensation
To preserve future fertility in male patients with cancer cryopreservation of sperm is recommended before chemo- or radiotherapy.
To compile data useful to physicians in counseling patients, we reviewed semen parameters according to the type of cancer, reproductive usage and choice of sperm disposition from our database.
Acknowledgements
Debbie Schafer, L.P.N., for her continuous commitment to patient care. Clarisa Gracia, M.D., for her help and support.
References (13)
- et al.
Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience
Fertil. Steril.
(1997) - et al.
Semen storage for special purposes at Monash IVF from 1977 to 1997
Fertil. Steril.
(1999) - et al.
Effect of cryopreservation on semen quality in patients with testicular cancer
Urology
(1995) - et al.
Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors
J. Clin. Oncol.
(2002) The influence of radiation on fertility in man
Br. J. Radiol.
(1980)- Shanin MS, Puscheck E. Reproductive sequelae of cancer treatment. Obstet Gynecol Clin...
Cited by (110)
Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome
2020, Fertility and SterilityFertility, ovarian reserve and cancer
2017, MaturitasFertility preservation in adult male patients with cancer: a systematic review and meta-analysis
2024, Human Reproduction OpenLong-Term Fertility Function Sequelae in Young Male Cancer Survivors
2023, World Journal of Men's Health